A clinical formulation indicated for Antivirals. This treatment supports the management of viral replication to promote faster recovery times and reduced symptom severity.
Formulated to manage influenza infections by addressing viral replication to alleviate symptom severity and support faster recovery during flu seasons.
Mechanism of Action
Oseltamivir blocks the neuraminidase enzyme on the surface of flu viruses. This enzyme is needed for the virus to release from infected cells and spread to others, thus limiting the infection's reach.
Route of Administration
Oral
Onset Time
24–48 hours
Duration
12 hours (dose dependent)
Contraindications
Hypersensitivity to oseltamivir, Severe kidney impairment (requires dose adjustment)
Severe Adverse Events
Severe neuropsychiatric events (hallucinations), Serious skin reactions (SJS), Severe allergic reactions, Liver failure
Information for Tamiflu is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
